BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22410438)

  • 1. Susceptibility of estrogen receptor rapid responses to xenoestrogens: Physiological outcomes.
    Marino M; Pellegrini M; La Rosa P; Acconcia F
    Steroids; 2012 Aug; 77(10):910-7. PubMed ID: 22410438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta acts as a dominant regulator of estrogen signaling.
    Pettersson K; Delaunay F; Gustafsson JA
    Oncogene; 2000 Oct; 19(43):4970-8. PubMed ID: 11042684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional flavonoids modulate estrogen receptor alpha signaling.
    Virgili F; Acconcia F; Ambra R; Rinna A; Totta P; Marino M
    IUBMB Life; 2004 Mar; 56(3):145-51. PubMed ID: 15185748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen signaling: a subtle balance between ER alpha and ER beta.
    Matthews J; Gustafsson JA
    Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
    Kostelac D; Rechkemmer G; Briviba K
    J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin and 17beta-estradiol coadministration prevents hormone-induced human cancer cell growth.
    Bulzomi P; Bolli A; Galluzzo P; Leone S; Acconcia F; Marino M
    IUBMB Life; 2010 Jan; 62(1):51-60. PubMed ID: 19960539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenoestrogens alter estrogen receptor (ER) α intracellular levels.
    La Rosa P; Pellegrini M; Totta P; Acconcia F; Marino M
    PLoS One; 2014; 9(2):e88961. PubMed ID: 24586459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between estrogen and mechanical strain effects on U2OS human osteosarcoma cells are not influenced by estrogen receptor type.
    Lima F; Vico L; Lafage-Proust MH; van der Saag P; Alexandre C; Thomas T
    Bone; 2004 Nov; 35(5):1127-35. PubMed ID: 15542038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation.
    Galluzzo P; Caiazza F; Moreno S; Marino M
    Endocr Relat Cancer; 2007 Mar; 14(1):153-67. PubMed ID: 17395984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways.
    Alonso-Magdalena P; Ropero AB; Soriano S; García-Arévalo M; Ripoll C; Fuentes E; Quesada I; Nadal Á
    Mol Cell Endocrinol; 2012 May; 355(2):201-7. PubMed ID: 22227557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and Xenobiotics.
    Nagel SC; Hagelbarger JL; McDonnell DP
    Endocrinology; 2001 Nov; 142(11):4721-8. PubMed ID: 11606437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphenol A impairs estradiol-induced protective effects against DLD-1 colon cancer cell growth.
    Bolli A; Bulzomi P; Galluzzo P; Acconcia F; Marino M
    IUBMB Life; 2010 Sep; 62(9):684-7. PubMed ID: 20836126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems.
    Kuiper GG; Shughrue PJ; Merchenthaler I; Gustafsson JA
    Front Neuroendocrinol; 1998 Oct; 19(4):253-86. PubMed ID: 9799586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens.
    Silva E; Kabil A; Kortenkamp A
    Toxicol Appl Pharmacol; 2010 Jun; 245(2):160-70. PubMed ID: 20206645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenoestrogen regulation of ERα/ERβ balance in hormone-associated cancers.
    Acconcia F; Fiocchetti M; Marino M
    Mol Cell Endocrinol; 2017 Dec; 457():3-12. PubMed ID: 27816767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
    Saha T; Makar S; Swetha R; Gutti G; Singh SK
    Eur J Med Chem; 2019 Sep; 177():116-143. PubMed ID: 31129450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of xenobiotics with estrogen receptors alpha and beta and a putative plasma sex hormone-binding globulin from channel catfish (Ictalurus punctatus).
    Gale WL; Patiño R; Maule AG
    Gen Comp Endocrinol; 2004 May; 136(3):338-45. PubMed ID: 15081833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator.
    Penttinen P; Jaehrling J; Damdimopoulos AE; Inzunza J; Lemmen JG; van der Saag P; Pettersson K; Gauglitz G; Mäkelä S; Pongratz I
    Endocrinology; 2007 Oct; 148(10):4875-86. PubMed ID: 17628008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.